Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Change in Acquisitions & Divestments (2022 - 2025)

Historic Change in Acquisitions & Divestments for Veracyte (VCYT) over the last 3 years, with Q3 2025 value amounting to $51.1 million.

  • Veracyte's Change in Acquisitions & Divestments changed N/A to $51.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $51.1 million, marking a year-over-year increase of 18899259.26%. This contributed to the annual value of $39.8 million for FY2023, which is 21385.54% up from last year.
  • As of Q3 2025, Veracyte's Change in Acquisitions & Divestments stood at $51.1 million.
  • In the past 5 years, Veracyte's Change in Acquisitions & Divestments ranged from a high of $51.1 million in Q3 2025 and a low of -$15000.0 during Q4 2022
  • For the 3-year period, Veracyte's Change in Acquisitions & Divestments averaged around $17.3 million, with its median value being $6.3 million (2022).
  • The largest annual percentage gain for Veracyte's Change in Acquisitions & Divestments in the last 5 years was 28000.0% (2023), contrasted with its biggest fall of 28000.0% (2023).
  • Veracyte's Change in Acquisitions & Divestments (Quarter) stood at -$15000.0 in 2022, then soared by 280.0% to $27000.0 in 2023, then skyrocketed by 188992.59% to $51.1 million in 2025.
  • Its last three reported values are $51.1 million in Q3 2025, $27000.0 for Q4 2023, and $39.8 million during Q1 2023.